0001104659-21-079413.txt : 20210610 0001104659-21-079413.hdr.sgml : 20210610 20210610160626 ACCESSION NUMBER: 0001104659-21-079413 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210608 FILED AS OF DATE: 20210610 DATE AS OF CHANGE: 20210610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harshbarger Benjamin CENTRAL INDEX KEY: 0001653133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 211008114 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 tm2119390-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-06-08 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001653133 Harshbarger Benjamin C/O CATABASIS PHARMACEUTICALS, INC., 100 HIGH STREET, FLOOR 28 BOSTON, MA 02110 0 1 0 0 Chief Legal Officer Stock Option (right to buy) 2.16 2021-06-08 4 A 0 200000 0 A 2031-06-07 Common Stock 200000 200000 D The option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2021 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. /s/ Benjamin Harshbarger 2021-06-10